INDRAMEDCO Intraday Analysis...

INDRAMEDCO Share Price

Open 58.40 Change Price %
High 59.00 1 Day -0.10 -0.17
Low 57.60 1 Week -2.55 -4.22
Close 57.85 1 Month 4.80 9.05
Volume 214086 1 Year 1.95 3.49
52 Week High 64.50
52 Week Low 48.90
INDRAMEDCO Important Levels
Resistance 2 59.15
Resistance 1 58.61
Pivot 58.15
Support 1 57.09
Support 2 56.55
NSE INDIA Most Active Stocks
JPASSOCIAT 28.95 8.02%
SUZLON 19.10 1.06%
UNITECH 9.30 -1.06%
LITL 1.10 4.76%
KPIT 127.30 2.83%
JPPOWER 8.35 7.05%
GMRINFRA 19.15 1.86%
FEDERALBNK 115.00 -3.64%
ALOKTEXT 4.00 17.65%
GTLINFRA 7.60 18.75%
More..
NSE INDIA Top Gainers Stocks
VISESHINFO 0.15 50.00%
FCSSOFT 0.25 25.00%
GET&D 394.00 19.76%
IVRCLINFRA 6.50 19.27%
GTLINFRA 7.60 18.75%
HANUNG 5.15 18.39%
SUJANAUNI 1.30 18.18%
ALOKTEXT 4.00 17.65%
GUJNREDVR 2.65 15.22%
BHUSANSTL 74.80 14.11%
More..
NSE INDIA Top Losers Stocks
KSERASERA 0.10 -33.33%
NAKODA 0.30 -14.29%
XLENERGY 1.70 -8.11%
NFL 73.20 -6.99%
RENUKA 20.25 -6.90%
RESPONIND 61.80 -6.65%
LAKSHVILAS 183.35 -5.95%
RSYSTEMS 44.15 -5.76%
SGL 17.90 -5.29%
SGL 17.90 -5.29%
More..

Indraprastha Medical Corporation Limited (NSE: INDRAMEDCO)

INDRAMEDCO Technical Analysis 3
As on 26th Jul 2017 INDRAMEDCO Share Price closed @ 57.85 and we RECOMMEND Buy for LONG-TERM with Stoploss of 54.85 & Buy for SHORT-TERM with Stoploss of 54.58 we also expect STOCK to react on Following IMPORTANT LEVELS.
INDRAMEDCO Target for July
1st Target up-side 54.69
2nd Target up-side 56.08
3rd Target up-side 57.48
1st Target down-side 50.71
2nd Target down-side 49.32
3rd Target down-side 47.92
INDRAMEDCO Synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
Bullish
100 Day EMA Close is Above EMA 100 (Mid Term) Bullish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Grater Then SIGNAL Line Bullish
RSI (14) RSI is 61.33 Sideways
MFI (14) MFI is 66.99 Sideways
CCI (20) CCI is Above 100 Over Bought
WILLIAM %R (14) William %R is -38.12 Sideways
ADX (14) ADX is Above 20 & +DI is Above -DI Up Trend
PSAR Stoploss For Long Buy 55.42
10 Day Avg Volume Traded -44.59 % Less then 10 Day Average Volume
INDRAMEDCO Other Details
Segment EQ
Market Capital 1540801536.00
Sector Healthcare
Industry Hospitals
Offical website http://www.apollohospdelhi.com
INDRAMEDCO Address
INDRAMEDCO
Sarita Vihar
Delhi Mathura Road
New Delhi, 110076
India
Phone: 91 11 2692 5858
Fax: 91 11 2682 5563
INDRAMEDCO Latest News
M Ravindran appointed as Chairman of Indraprastha Gas Limited   Jagran Josh   - 10th Feb 15
Financial Results & Limited Review for Dec 31, 2014 (Standalone)   Hindu Business Line   - 29th Jan 15
Congress manifesto for the Delhi Assembly election   The Hindu   - 24th Jan 15
Change in Directorship   Hindu Business Line   - 06th Jan 15
Indraprastha Medical Corp's director MM Kutty resigns   Moneycontrol.com   - 06th Jan 15
Indraprastha Medical Corporation appoints DM Spolia as Chief Secretary   Moneycontrol.com   - 07th Nov 14
ICRA ratings for Indian debt instruments-Sep 22   Reuters   - 22nd Sep 14
Buy Indraprastha Medical; tgt of Rs 51: Firstcall Research   Moneycontrol.com   - 28th May 14
Indraprastha Medical Corporation Limited   Moneycontrol.com   - 28th Jan 14
Indraprastha Medical Corporation appoints SN Sahai as principle secretary   Moneycontrol.com   - 12th Dec 12
Interactive Technical Analysis Chart Indraprastha Medical Corporation Limited ( INDRAMEDCO NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Indraprastha Medical Corporation Limited
INDRAMEDCO Business Profile
Indraprastha Medical Corporation (Indraprastha) is a Delhi-based healthcare company which operates through Indraprastha Apollo Hospital. Indraprastha Apollo, a 695 bed specialty hospital, was commissioned Dec. 1995 in collaboration with New Delhi administration. The hospital spread across an area of 675,000 sq ft is the largest corporate hospital in India and the fourth largest in the world. The hospital has various centers such as Apollo cardiac center, Apollo cancer center, Apollo surgical science center among others. The hospital undertakes activities like health check-ups, transplants, cardiac and other surgeries. The company has operated on around 7.4 million patients. The group also owns 12 hospitals and four clinics. The company posted a sales growth of 17.8% at Rs 584.32 million for quarter ended Sep. 2006, as against Rs 496.07 million for the previous quarter ended September 2005. Net profit increased 3.52% at Rs 17.06 million as against Rs 16.48 million. The company`s net profit for the year ended Mar. 2006 stood at Rs 166.61 million while EPS stood at Rs 1.82. The current market capitalization stands at Rs 327.27 crore. The company has reported a standalone sales of Rs 177.25 crore and a Net Profit of Rs 10.89 crore for the quarter ended September 2013. The company management includes D M Spolia - Chairman, Prathap C Reddy - Vice Chairman, Jaideep Gupta - Managing Director, B Venkataraman - Director, Deepak Vaidya - Director, Ranjit Roy Chaudhury - Director, Renu S Karnad - Director, S C L Das - Director, Satnam Arora - Director, S Regunathan - Director, Shobana Kamineni - Director, Suneeta Reddy - Director, T S Narayanasami - Director, Vijay Lall - Director, V N Rajasekharan Pillai - Director, Archana Arora - Additional Director. The Registered office is at Sarita Vihar, Delhi-Mathura Road, New Delhi, Delhi - 110076.